article on eastern vs western medicine
NEW YORK (Reuters Health) – Patients with multiple myeloma mount a highly variable antibody response after completing the recommended two-dose
Read more
First COVID jab provides protection for most myeloma blood cancer patients
A single dose of a COVID-19 vaccine triggers an immune response in around 70% of patients with myeloma—suggesting that it
Read more
zyrtec sinus pressure
PARIS, March 31, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has approved Sarclisa (isatuximab-irfc) in combination with
Read moreASH: Adding Subcutaneous Daratumumab Slows Advanced Multiple Myeloma
TUESDAY, Dec. 8, 2020 — For patients with relapsed/refractory multiple myeloma (RRMM), subcutaneous daratumumab plus pomalidomide and dexamethasone (D-Pd) reduces
Read more
Triplet Therapy Slows Refractory Multiple Myeloma
WEDNESDAY, Nov. 18, 2020 — A once-weekly regimen of selinexor, bortezomib, and dexamethasone slows the progression of relapsed or refractory
Read more
BCMA-targeted immunotherapy can lead to durable responses in multiple myeloma
An experimental, off-the-shelf immunotherapy that combines a targeted antibody and chemotherapy can lead to potentially durable responses in multiple myeloma
Read more